Sanofi India Dividend 2026 announcement brings good news for shareholders, with the pharmaceutical company declaring an interim dividend of Rs 75 per equity share for the financial year 2026.
The company has also fixed November 5, 2026, as the record date to determine which shareholders will be eligible for the payout.
The decision was announced on October 29, 2026, alongside the company’s financial results for the quarter ended September 30, 2026.
The declared dividend is on shares with a face value of Rs 10 each.
Sanofi India Dividend 2026: Key Details
Sanofi India has announced an interim dividend of Rs 75 per equity share.
Shareholders whose names appear in the company’s records on the specified record date will be eligible to receive the dividend, subject to the applicable rules.
The key details are:
Dividend amount: Rs 75 per equity share
Face value: Rs 10 per share
Record date: November 5, 2026
Announcement date: October 29, 2026
Financial year: 2026
The company has stated that the dividend will be paid within the stipulated timelines.
 What Is the Record Date for Sanofi India Dividend?
The company has fixed Thursday, November 5, 2026, as the record date for the interim dividend. This date will be used to identify eligible shareholders.
Investors holding Sanofi India shares should pay attention to the record date and the applicable settlement timelines.
Simply purchasing shares on the record date may not make an investor eligible, as the shares must be credited in the required manner under the prevailing market settlement rules.
The Sanofi India dividend announcement is therefore important for existing shareholders as well as investors tracking the company’s corporate actions.
Sanofi India Q3 Results 2026: Profit Rises 54%
Along with the dividend announcement, Sanofi India reported its financial performance for the quarter ended September 30, 2026.
The company’s net profit increased to Rs 117 crore, compared with Rs 76 crore in the corresponding quarter of the previous year. This represents a year-on-year growth of around 54%.
Revenue also recorded an increase.
The company reported revenue of Rs 492 crore for the quarter, compared with Rs 475 crore in the year-ago period, marking growth of approximately 3.6%.
Its earnings before interest, tax, depreciation and amortisation (EBITDA) rose to Rs 161 crore from Rs 133 crore a year earlier.
The EBITDA margin improved to 32.8%, compared with 28.1% in the corresponding period.
What Should Shareholders Know?
The Rs 75 interim dividend is a corporate action announced by Sanofi India for the financial year 2026.
Eligible investors should check their demat account details and ensure that their shareholding is reflected correctly by the relevant record date.
Investors should also remember that dividend payments are subject to applicable tax rules.
The actual amount received may differ depending on individual tax circumstances.
The company’s dividend announcement and quarterly results provide shareholders with two important updates.
While the dividend sets out the proposed payout, the Q3 figures show an increase in profit and revenue compared with the same period last year.
